|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Personal history of malignant neoplasm of skin
ICD-10 (CM) Code and Descriptor
|
Z85.828 |
Personal history of other malignant neoplasm of skin
This code is considered unacceptable as a principal diagnosis.
|
Z85828 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 2.99%
|
10.60%
|
11.68%
|
11.09%
|
10.12%
|
9.18%
|
7.80%
|
6.49%
|
5.41%
|
4.56%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z85.828*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
19,485
|
19,519
|
|
17000
|
DESTRUCT PREMALG LESION |
4,080
|
4,081
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
3,183
|
9,925
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,564
|
3,435
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,245
|
2,257
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,619
|
1,619
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,601
|
1,601
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
1,499
|
1,499
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
1,029
|
1,029
|
|
17110
|
DESTRUCT B9 LESION 1-14 |
906
|
919
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
609
|
609
|
|
11103
|
TANGNTL BX SKIN EA SEP/ADDL |
454
|
589
|
|
99212
|
OFFICE O/P EST SF 10 MIN |
436
|
437
|
|
85027
|
COMPLETE CBC AUTOMATED |
382
|
382
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
366
|
366
|
|
17004
|
DESTROY PREMAL LESIONS 15/> |
344
|
344
|
|
83735
|
ASSAY OF MAGNESIUM |
313
|
314
|
|
84443
|
ASSAY THYROID STIM HORMONE |
292
|
294
|
|
84100
|
ASSAY OF PHOSPHORUS |
258
|
258
|
|
80061
|
LIPID PANEL |
252
|
252
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z85.828 related to the following DRG Codes:
826-828
829-830
843-845
|
